Navigation Links
Reportlinker Adds H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays) Report
Date:9/24/2009

NEW YORK, Sept. 24 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.

H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays)

http://www.reportlinker.com/p0119228/H1N1-(Swine-Influenza)-Market-Assessment-(Latest-Data-Company-Profiles-Implications-for-Immunoassays-and-Molecular-Assays).html

The outbreak of swine flu is highlighting the public health importance of improved testing techniques and providing market opportunities for manufacturers of diagnostic tests and other products related to the disease. These conclusions and others appear in a new report released from Kalorama Information: Swine Flu Market Alert by Kalorama's lead analyst, Shara Rosen.

Regardless of the eventual severity of the epidemic, there will be distinct market impact on both immunoassay and molecular test makers, according to the report. The makers of certain tests will benefit both in terms of sales and more broadly in recognition that their products play a vital role in making the public health community significantly better prepared for this possible pandemic than 1968 or before.

The report examines:

  • Market Impact likely for immunoassays and molecular testing.
  • Lessons from previous epidemics, likely impact on both immunoassays and molecular testing.
  • Overview of the H1N1 strain as compared to other.
  • Immunoassay and Molecular Test Products Available on the Market
  • Developments in the last few days of significance to the diagnostic industry.
  • Profiles of nearly 25 specific manufacturers active in this space.

The report focuses almost exclusively on the in vitro diagnostic industry as it applies to work being done by commercial entities and products that are either in development or have been brought to market.

The market assessment provided has been assembled based on publicly available information. Company sales data and other quantitative evaluations of the markets for flu diagnostics have been developed based on publicly available information and are expressed in US dollars, no adjustments have been made for currency exchange fluctuations.

Under normal circumstances, a report of this genre would be assembled from information derived from primary and secondary sources. However, in the short time it took to research and write this report, almost all of the major scientific and industry experts were occupied with the extraordinary task of preparing for a pandemic.

Therefore the information contained in this report has been assembled from a vast array of scientific and market publications, government sources, analyzed by a professional analyst.

CHAPTER ONE: EXECUTIVE SUMMARY

  • Background
  • Exhibit 1: Flu Epidemics Compared to Present 1918-Today
  • Scope And Methodology
  • Point of View
  • Information Sources

CHAPTER TWO: 2009 SWINE INFLUENZA AND OTHER FLU EPIDEMICS

  • Influenza Overview
  • Overview of Virus Types
  • What's So Special About This Latest Flu?
  • Flu Therapeutics
  • WHO Global Influenza Preparedness Plan

CHAPTER THREE: FLU DIAGNOSTICS

  • Background
  • Exhibit 2: Influenza Test Innovations, 2009 (Company, Technology, Test Details, Status)
  • Immunoassays
    • Rapid Testing
    • Market Performance of Rapid Test
    • New Entrant Possibility
    • Conclusion: Impact of Swine Flu on Rapid Testing
  • Molecular Assays
    • Molecular Influenza Detection Techniques
    • PCR, Sequencing or Both
    • Lessons and Market Impact of the H5N1 Epidemic

CHAPTER FOUR: PROGNOSIS FOR A/H1N1

  • Background
  • Pandemic - Where? When?
    • 1976 Hsw1N1 Swine Flu Case
    • Comparing Past Flu Epidemics to 2009
    • International Reaction
  • Swine Flu and the IVD Industry
    • Origin of Flu Virus Mixes
    • PCR Test Development
    • Late-Breaking Research Developments
    • Use of Rapid Tests in Current Epidemic

CHAPTER FIVE: COMPANIES AND PRODUCTS IMPACTED BY SWINE FLU EPIDEMIC

  • Immunoassays
    • 3M Medical Diagnostics
    • Becton, Dickinson and Company (BD)
    • Genzyme Corporation
    • Inverness Medical Innovations
    • Meridian Bioscience, Inc.
    • Quidel Corporation
    • Remel, Inc.
    • Response Biomedical Corporation
  • Molecular Tests
    • Arbor Vita Corporation
    • CombiMatrix Molecular Diagnostics (CMDX)
    • Diagnostic HYBRIDS, Inc. (DHI)
    • eGene Inc.
    • Eiken Chemical Co., Ltd
    • Life Technologies/Applied Biosystems/ Invitrogen Corporation (ABI)
    • Lab21
    • Laboratory Corporation of America Holdings (LabCorp)
    • Luminex Corporation
    • Nanogen
    • Prodesse Inc.
    • Qiagen N.V.
    • Seegene Inc.
    • Veredus Laboratories Pte

To order this report:

H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays)

http://www.reportlinker.com/p0119228/H1N1-(Swine-Influenza)-Market-Assessment-(Latest-Data-Company-Profiles-Implications-for-Immunoassays-and-Molecular-Assays).html

More market research reports here!

    Nicolas Bombourg
    Reportlinker
    Email: nbo@reportlinker.com
    US: (805)652-2626
    Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Reportlinker Adds Biologic Imaging Reagents: Technologies and Global Markets Report
2. Reportlinker Adds Dermatological Therapeutics: Global Markets Report
3. Reportlinker Adds Markets for Advanced Wound Care Technologies Report
4. Reportlinker Adds Antiseptics and Disinfectants Report
5. Reportlinker Adds Commercial Amino Acids Report
6. Reportlinker Adds Membrane & Separation Technology News Review, 2008 Report
7. Reportlinker Adds the Dental Market: Techniques, Equipment and Materials Report
8. Reportlinker Adds Pediatric Health Care Products and Services Report
9. Reportlinker Adds Botanical and Plant-Derived Drugs: Global Markets Report
10. Reportlinker Adds 2008/2009 Healthcare Research Review Report
11. Reportlinker Adds Therapeutics and Diagnostics for Womens Disorders Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... December 06, 2016 , ... The ... in developing a vaccine against the Middle East Respiratory Syndrome Coronavirus (MERS-CoV). The ... in South Korea for emergency deployment in the event of a future outbreak. ...
(Date:12/6/2016)... ... ... Individuals who seek to reduce the effects of aging can take up ... to the sun, according to a November 30 article published on Medical ... while preventive measures to help keep ourselves looking our best always make sense, individuals ...
(Date:12/6/2016)... , ... December 06, 2016 , ... An inventor, from ... utilize a sling, so she invented the patent-pending SLING-VEST. , The SLING-VEST provides an ... offers an improved alternative to traditional slings. As a result, it helps to reduce ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... prescriptive health insights for population health management, announces today a strategic relationship ... leverage CitiusTech’s cloud-hosted clinical rules engine that offers advanced Clinical Quality Measures ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... the Maine Women’s Magazine inaugural Maine Women’s Expo. Hundreds of women gathered to ... amazing local resource. The expo’s beneficiary this year was Crossroads, a fully-accredited ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... , Dec. 6, 2016   AlloSource , ... cellular, bone, skin and soft-tissue allografts for use ... Business Process Manager, for being named to the ... National Quality Award by the Commerce Department,s National ... organization,s commitment to process excellence. The Baldrige Award ...
(Date:12/6/2016)... , Dec. 6, 2016  BTL Aesthetics ... proving that its BTL Vanquish ME device was ... energy delivery to the targeted tissue. The result: ... 53% higher, with BTL Vanquish ME versus BTL ... our physician network and their patients with the ...
(Date:12/6/2016)... 2016 With opioids commonly used for pain management for ... market that has led to nationwide fatalities. The synthetic ... stronger than heroin or morphine, resulting in likelihood of addiction, abuse ... , , ... clinical operations, Behavioral Health for HMC HealthWorks, explained the opioid drug ...
Breaking Medicine Technology: